These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1339054)

  • 1. [Effect of aminoglutethimide on ACTH plasma levels in Cushing's disease and Nelson syndrome].
    Kasperlik-Załuska AA; Migdalska B; Jeske W; Niegowska E; Wiśniewska-Woźniak T
    Pol Tyg Lek; 1992 Nov 2-9; 47(44-45):1006-8. PubMed ID: 1339054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease.
    van Aken MO; Pereira AM; van den Berg G; Romijn JA; Veldhuis JD; Roelfsema F
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):765-72. PubMed ID: 15163342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adrenostatic treatment of ACTH-dependent Cushing syndrome using metyrapone and aminoglutethimide].
    Reincke M; Allolio B; Jaursch-Hancke C; Kaulen D; Winkelmann W
    Dtsch Med Wochenschr; 1987 Oct; 112(40):1532-5. PubMed ID: 2820688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of sodium valproate on plasma ACTH and cortisol concentrations in Cushing's disease and Nelson's syndrome.
    Kasperlik-Załuska A; Drac-Kaniewska J; Migdalska B; Jeske W; Wiśniewska-Woźniak T
    Endokrynol Pol; 1988; 39(5):245-52. PubMed ID: 2855625
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of aminoglutethimide on hypothalamic-pituitary-adrenal functions.
    Pan CY; Luo GC; Li JY; Wang YZ; Lu SZ; Ma SQ; Guo AY
    Chin Med J (Engl); 1989 Nov; 102(11):890-4. PubMed ID: 2561555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of magnesium valproate on plasma ACTH concentrations in Nelson's syndrome.
    Kasperlik-Załuska A; Migdalska B; Jeske W; Drac-Kaniewska J; Wiśniewska-Woźniak T
    Acta Med Pol; 1989; 30(1-2):9-15. PubMed ID: 2562233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACTH responses to somatostatin, valproic acid and dexamethasone in Nelson's syndrome.
    Kasperlik-Załuska AA; Zgliczyński W; Jeske W; Zdunowski P
    Neuro Endocrinol Lett; 2005 Dec; 26(6):709-12. PubMed ID: 16380696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug controlled of Cushing's syndrome. Combined aminoglutethimide and metyrapone therapy.
    Child DF; Burke CW; Burley DM; Rees LH; Fraser TR
    Acta Endocrinol (Copenh); 1976 Jun; 82(2):330-41. PubMed ID: 179256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation and treatment of Cushing's syndrome.
    Nieman LK; Ilias I
    Am J Med; 2005 Dec; 118(12):1340-6. PubMed ID: 16378774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of using basal plasma adrenocorticotropic hormone-radioimmunoassay (ACTH-RIA) level in the identification of the cause of Cushing's syndrome.
    Sriussadaporn S; Ploybutr S; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A
    J Med Assoc Thai; 1997 Apr; 80(4):233-41. PubMed ID: 9175392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Is it possible to predict the development of Nelson's syndrome in Cushing's disease after bilateral adrenalectomy?].
    Horký K; Kanka J; Gregorová I; Tomsová Z; Dvoráková J
    Cas Lek Cesk; 1990 May; 129(21):645-9. PubMed ID: 2164450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of ACTH lowering effect of sodium valproate in patients with ACTH hypersecretion.
    Loli P; Berselli ME; Frascatani F; Muratori F; Tagliaferri M
    J Endocrinol Invest; 1984 Apr; 7(2):93-6. PubMed ID: 6327800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome.
    Castro M; Elias LL; Elias PC; Moreira AC
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of sodium valproate in Cushing's disease, Nelson's syndrome and Addison's disease.
    Reincke M; Allolio B; Kaulen D; Jaursch-Hancke C; Winkelmann W
    Klin Wochenschr; 1988 Aug; 66(15):686-9. PubMed ID: 2845188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A correlative study between cortisol and ACTH in Cushing's disease following bilateral adrenalectomy and in Nelson's syndrome.
    Kasperlik-Załuska A; Niegowska E; Migdalska B; Jeske W; Zieliński M
    Endokrynol Pol; 1992; 43(3):314-21. PubMed ID: 1345571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of the long-acting somatostatin analogue SMS 201-995 on ACTH secretion in Nelson's syndrome and Cushing's disease.
    Lamberts SW; Uitterlinden P; Klijn JM
    Acta Endocrinol (Copenh); 1989 Jun; 120(6):760-6. PubMed ID: 2543178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of high-dose and low-dose naloxone on plasma ACTH in patients with ACTH hypersecretion.
    Deuss U; Allolio B; Kaulen D; Fischer H; Winkelmann W
    Clin Endocrinol (Oxf); 1985 Mar; 22(3):273-9. PubMed ID: 2983909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [ACTH plasma levels in patients after total bilateral adrenalectomy for Cushing's syndrome (author's transl)].
    Dolecek R; Kopriva P; Závada M
    Cas Lek Cesk; 1978 Apr; 117(16):493-8. PubMed ID: 207430
    [No Abstract]   [Full Text] [Related]  

  • 19. Ketoconazole treatment in Cushing's disease. Effect on the circadian profile of plasma ACTH and cortisol.
    Terzolo M; Panarelli M; Piovesan A; Torta M; Paccotti P; Angeli A
    J Endocrinol Invest; 1988 Nov; 11(10):717-21. PubMed ID: 2852693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of sodium-valproate administration on plasma ACTH levels in patients with ACTH hypersecretion.
    Ambrosi B; Bochicchio D; Riva E; Faglia G
    J Endocrinol Invest; 1983 Aug; 6(4):305-6. PubMed ID: 6315806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.